Patent application number | Description | Published |
20090323575 | METHOD AND APPARATUS FOR MULTICASTING WITHIN A WIRELESS COMMUNICATION NETWORK - A number of uplink transmissions from multiple remote devices is received. The remote devices correspond to a single network node, and each of the uplink transmissions corresponds to a request for content. A subset of remote devices whose uplink transmissions correspond to requests for common content is identified and a Quality of Service (QoS) level corresponding to the number of remote devices in the identified subset is determined. The common content is transmitted to the single network node at the determined QoS level. | 12-31-2009 |
20130115995 | METHOD AND APPARATUS FOR ENSURING CRITICAL RESOURCE ALLOCATION FOR GROUP CALLS MADE IN A PUSH-TO-TALK COMMUNICATION ENVIRONMENT - Critical resource data ( | 05-09-2013 |
20130136036 | METHOD AND APPARATUS FOR MANAGING QUALITY OF SERVICE SETTINGS FOR GROUP COMMUNICATIONS - A centralized quality of service (QoS) entity having a processing device performs a method for managing QoS settings for group communications. The method includes: determining a plurality of active participants of a group communication session; and determining, for each active participant, an individual QoS setting, including a first individual QoS setting for a first active participant. The method further includes modifying the first individual QoS setting based on the individual QoS setting for at least one other active participant, wherein the modified first individual QoS setting is applied to a session leg used by the first active participant during the group communication session. The active participants of the group communication session can be on the same or heterogeneous wireless networks. | 05-30-2013 |
20130171955 | METHODS AND APPARATUS FOR DETECTING AND MITIGATING RADIO INTERFERENCE AMONG USER EQUIPMENT AND BASE STATIONS OF GEOGRAPHICALLY CO-LOCATED AND SPECTRALLY DISTINCT WIRELESS SYSTEMS - Methods and apparatus are provided for detecting interference between spectrally distinct wireless communication networks. A first base station in a first network communicates with a first mobile device at a first frequency, and a second base station communicates at a second frequency with a second mobile device geographically co-located with the first mobile device. The power level of an interfering signal received at the first base station from the second mobile device may be estimated by sharing information between the two networks through an interoperability gateway. The path loss of a reference signal transmitted from the first mobile device to its base station is communicated to the gateway, along with a parameter associated with the transmit power level of the interfering signal. Based on this parameter and the reference signal path loss, the received power level of the interfering signal may be inferred. | 07-04-2013 |
20140105040 | METHOD AND APPARATUS FOR UPLINK POWER CONTROL IN AN ORTHOGONAL FREQUENCY DIVISION MULTIPLE ACCESS COMMUNICATION SYSTEM - A communication system minimizes inter-cell interference and handover holes by providing for a user equipment (UE) to monitor downlink signals from a serving, boundary eNodeB and one or more neighbor eNodeBs, determine a signal quality metric (SQM) for each monitored signal to produce an SQM associated with each eNodeB, and determine a maximum uplink transmit power level (PMAX) for each eNodeB. Based on the determined SQMs and PMAXs, the UE determines a eNodeB of the one or more neighbor eNodeBs with a best SQM and, in response to determining that the neighbor eNodeB of the one or more neighbor eNodeBs with a best SQM is a high power eNodeB, determines a difference between the SQM associated with the high power ENodeB and the SQM associated with the boundary eNodeB. The UE then sets a PMAX for the UE based on the difference determination. | 04-17-2014 |
20140122721 | METHOD AND APPARATUS FOR SUPPORTING CROSS JURISDICTIONAL MUTUAL AID REQUESTS - The same priority is applied to all resources assigned to an incident. A first dispatch system in a first network assigns a network resource in the first network to an incident that occurred in a first jurisdiction. The first dispatch system requests a mutual aid resource from a second dispatch system in a second network subsequent to identifying a resource gap in the first network. The first dispatch system obtains the mutual aid resource from the second dispatch system. A first policy component in the first network receives, from at least one of a first prioritization service in the first network and the at least one second network, at least one of an incident information or a mutual aid information. The first policy component correlates the mutual aid resource with obtained incident information and assigns a same priority to the network resource and the mutual aid resource. | 05-01-2014 |
20140187190 | METHOD AND APPARATUS FOR RECEIVING A DATA STREAM DURING AN INCIDENT - A method and apparatus are provided, for accessing a data-capture device in a different domain, by public safety wireless communications equipment, for the purpose of obtaining information at an incident. A dispatch controller of a public safety wireless communications system receives an access token from a server of a non-public-safety network, when an incident occurs. The token allows access to a data-capture device, and is associated with the incident. The dispatch controller sends the token to the data-capture device, receives a data stream, and forwards the data stream to a public safety wireless communication device. The public safety wireless communication device may itself discover and access the data-capture device, and may receive the data stream directly from the data-capture device. The public safety wireless communication device may forward the data stream and/or the access token to other public safety wireless communication devices. | 07-03-2014 |
Patent application number | Description | Published |
20100029686 | HCV PROTEASE INHIBITORS AND USES THEREOF - This invention relates to: (a) compounds of formula I and salts thereof that, inter alia, are useful as hepatitis C virus (HCV) inhibitors; (b) intermediates useful for the preparation of such compounds and salts; (c) pharmaceutical compositions comprising such compounds and salts; and (d) methods of use of such compounds, salts, and compositions. | 02-04-2010 |
20100144608 | Macrocyclic hepatitis C serine protease inhibitors - The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient. | 06-10-2010 |
20110003827 | HIV protease inhibiting compounds - A compound of the formula | 01-06-2011 |
20120083490 | CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF - The present invention features compounds of formula I | 04-05-2012 |
20120101031 | MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS - The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient. | 04-26-2012 |
20120172291 | MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS - The present invention relates to novel fluorinated macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient. | 07-05-2012 |
20120196792 | MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS - The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient. | 08-02-2012 |
20120295842 | PHENANTHRIDINE MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS - The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient. | 11-22-2012 |
20120309762 | CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF - The present invention features compounds of formula I | 12-06-2012 |
20130023463 | HIV PROTEASE INHIBITING COMPOUNDS - A compound of the formula | 01-24-2013 |
20130131085 | CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF - The present invention features compounds of formula I | 05-23-2013 |
20130303547 | HCV Protease Inhibitors and Uses Thereof - This invention relates to: (a) compounds of formula I and salts thereof that, inter alia, are useful as hepatitis C virus (HCV) inhibitors; (b) intermediates useful for the preparation of such compounds and salts; (c) pharmaceutical compositions comprising such compounds and salts; and (d) methods of use of such compounds, salts, and compositions. | 11-14-2013 |
20140073700 | GLYCYRRHETINIC ACID DERIVATIVES AND METHODS OF USE THEREOF - The present application relates to: (a) compounds of Formula (I): | 03-13-2014 |
20140148573 | MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS - The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient. | 05-29-2014 |
20140243340 | CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF - The present invention features compounds of formula I | 08-28-2014 |
20140287992 | MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS - The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient. | 09-25-2014 |
Patent application number | Description | Published |
20090003467 | POWER PROFILE RESHAPING IN ORTHOONAL FREQUENCY DIVISION MULTIPLE ACCESS SYMBOLS - A method, information processing system, and base station for reshaping power profiles in Orthogonal Frequency Division Multiple Access (OFDMA) symbols. The method includes monitoring a scheduler ( | 01-01-2009 |
20090109960 | METHOD AND APPARATUS FOR A VIRTUAL CIRCUIT DATA AREA WITHIN A PACKET DATA FRAME - A method and apparatus for a virtual circuit data area within a packet data frame is disclosed. The method may include operating ( | 04-30-2009 |
20090149144 | WIRELESS BACKHAUL POWER AMPLIFICATION USING FOURIER TRANSFORM MATRICIES - An apparatus amplifies RF signals in a communication system by using a first directional coupler having at least two inputs and at least two outputs; at least two RF amplifiers, where an input of each RF amplifier is connected to a different one of the at least two outputs of the first directional coupler; and a second directional coupler having at least two inputs and at least two outputs, where each one of the at least two inputs is connected to an output of a different one of the at least two RF amplifiers. The at least two outputs of the second directional coupler are connected to at least two antennas, respectively. | 06-11-2009 |
20090168708 | TECHNIQUES FOR MAINTAINING QUALITY OF SERVICE FOR CONNECTIONS IN WIRELESS COMMUNICATION SYSTEMS - A technique for operating a wireless communication device includes assigning re-transmission identifiers, such as hybrid automatic repeat request (HARQ) channel identifications, automatic repeat request (ARQ) channel identifications, and ARQ Identifier Sequence Numbers, to at least a first re-transmission identifier group and a second re-transmission identifier group, wherein each re-transmission identifier group is associated with a different quality of service parameter. The technique identifies whether a committed quality of service is met for a connection based on whether a communication on the connection is associated with the first re-transmission identifier group or the second re-transmission identifier group. | 07-02-2009 |
20090274204 | METHOD AND APPARATUS FOR PROVIDING CHANNEL QUALITY FEEDBACK IN AN ORTHOGONAL FREQUENCY DIVISION MULTIPLEXING COMMUNICATION SYSTEM - In an OFDM communication system, a mobile station provides a radio access network (RAN) a channel quality metric second order statistic, in one embodiment a signal to noise plus interference power ratio (SINR) second order statistic and in particular an SINR standard deviation and/or variance, along with a mean channel quality metric, that is, a mean SINR. By providing both a mean channel quality metric and a channel quality metric second order statistic, the communication system permits the RAN to create a more accurate fading profile of an associated air interface, and in particular a downlink of the air interface, thereby facilitating an improved scheduling decision over the prior art and assuring that a packet has a higher probability to go through a downlink channel without too many retransmissions. | 11-05-2009 |
20100166098 | METHOD AND APPARATUS FOR ANTENNA SELECTION AND POWER CONTROL IN A MULTIPLE INPUT MULTIPLE OUTPUT WIRELESS COMMUNICATION SYSTEM - A MIMO base station is provided that includes a multi-channel transmitter having an input Fourier Transform Matrix (FTM) and an output FTM that are each coupled to an intervening signal processing section having multiple radio frequency (RF) amplifiers. A signal applied to an input port of the input FTM is distributed to all RF amplifiers of the transmitter by the input FTM and then is recombined by the output FTM such that the signal is routed to a single antenna of the multiple antennas of an antenna array. Thus, for both MIMO and non-MIMO transmissions, all RF amplifiers are used to amplify each input signal, but the non-MIMO transmission signal then is recombined such that only a single transmit antenna then is used to transmit the signal. The base station further provides antenna selection for a single antenna transmission and gain allocation among the multiple antennas for a MIMO transmission. | 07-01-2010 |
20110159911 | UPLINK POWER ALIGNMENT ESTIMATION IN A COMMUNICATION SYSTEM - A method and apparatus for uplink power alignment estimation in a communication system includes a step | 06-30-2011 |
20110267967 | METHOD AND APPARATUS FOR SCHEDULING A CONTROLCHANNEL IN AN ORTHOGONAL FREQUENCY DIVISION MULTIPLEXING COMMUNICATION SYSTEM - A scheduler capable of operating in an Orthogonal Frequency Division Multiplexing communication system schedules a control channel for a user equipment by determining a channel quality metric associated with the user equipment, calculating a target control channel element quality metric, determining a control channel element utilization rate, wherein the control channel element utilization rate a past rate of utilization of control channel elements, and selecting a control channel element aggregation level for the control channel based on the channel quality metric, the target control channel element quality metric, and the control channel element utilization rate. The scheduler then allocates control channel elements to the control channel based on the selected control channel element aggregation level. The scheduler further may steal power from one or more unused control channel elements and assign the stolen power to control channel elements assigned to the control channel. | 11-03-2011 |
20120275391 | GRANTING SCHEDULING REQUESTS IN A WIRELESS COMMUNICATION SYSTEM - Embodiments include methods and apparatus for granting scheduling requests in a wireless communications system that includes an eNB, a plurality of UEs, and a public safety system. The eNB receives multiple scheduling requests from multiple UEs, where each of the scheduling requests indicates that a corresponding UE is requesting uplink data transmission resources. The eNB determines a priority value for each of the scheduling requests based on multiple scoring criteria, resulting in a plurality of priority values associated with the scheduling requests. The eNB transmits one or more scheduling request grants to a subset of the UEs, where the subset includes one or more UEs that are associated with one or more scheduling requests having relatively high priority values. In an embodiment, the multiple scoring criteria include information associated with a public safety activity (e.g., a user role, a jurisdictional coverage area, an incident type, and/or an application type). | 11-01-2012 |
Patent application number | Description | Published |
20100232525 | System and Method for Channel Information Feedback in a Wireless Communications System - A system and method for channel information feedback in a wireless communications system is provided. A method for communications device operation includes receiving a pilot transmitted by a controller, computing a channel estimate for a channel between the controller and a communications device, the computing based on the pilot, computing a channel correlation matrix for the channel based on the channel estimate, and transmitting a reduced rank representation of the channel correlation matrix to the controller as a first feedback information. The method also includes adapting a first codebook based on the reduced rank representation of the channel correlation matrix, computing a representation of the channel using the adapted codebook, transmitting the representation of the channel as a second feedback information, and receiving a transmission beamformed based on the first feedback information and the second feedback information | 09-16-2010 |
20110103493 | System and Method for Wireless Communications with Adaptive Codebooks - A system and method for wireless communications with adaptive codebooks are provided. A method for communications node operations includes estimating a communications channel between the communications node and a controller serving the communications node, quantizing the estimated communications channel based on an adapted codebook, estimating statistics of the communications channel, transmitting a first indicator of the quantized estimated communications channel, adjusting the adapted codebook based on the estimated statistics, and receiving a transmission from the controller. The transmission is precoded based on the first indicator of the quantized estimated communications channel. | 05-05-2011 |
20140211874 | System and Method for Channel Information Feedback in a Wireless Communications System - A system and method for channel information feedback in a wireless communications system is provided. A method for communications device operation includes receiving a pilot transmitted by a controller, computing a channel estimate for a channel between the controller and a communications device, the computing based on the pilot, computing a channel correlation matrix for the channel based on the channel estimate, and transmitting a reduced rank representation of the channel correlation matrix to the controller as a first feedback information. The method also includes adapting a first codebook based on the reduced rank representation of the channel correlation matrix, computing a representation of the channel using the adapted codebook, transmitting the representation of the channel as a second feedback information, and receiving a transmission beamformed based on the first feedback information and the second feedback information. | 07-31-2014 |
Patent application number | Description | Published |
20090004241 | POLYMER NANOFILM COATINGS - Disclosed herein are nanofilm coatings for implantable medical devices comprising a diblock or triblock copolymer (PEO-PMMA or PMOXA-PDMS-PMOXA, respectively). Such nanofilms, may be used, for example, as amphiphilic supports for therapeutic agents. These materials are conducive towards the formation of active substrates for a suite of biological and medical applications. | 01-01-2009 |
20100040672 | DELIVERY OF THERAPEUTICS - The present invention provides materials and devices for the controlled release of therapeutics, and methods for uses thereof. | 02-18-2010 |
20100305309 | NANODIAMOND PARTICLE COMPLEXES - The present invention provides various functionalized nanodiamond particles. In particular, the present invention provides soluble complexes of nanodiamond particles and therapeutic agents, for example insoluble therapeutics, anthracycline and/or tetracycline compounds, nucleic acids, proteins, etc. | 12-02-2010 |
20130004560 | Polymer Nanofilm Coatings - Disclosed herein are nanofilm coatings for implantable medical devices comprising a diblock or triblock copolymer (PEO-PMMA or PMOXA-PDMS-PMOXA, respectively). Such nanofilms, may be used, for example, as amphiphilic supports for therapeutic agents. These materials are conducive towards the formation of active substrates for a suite of biological and medical applications. | 01-03-2013 |
Patent application number | Description | Published |
20090035291 | THERAPEUTIC USE OF ADPASE ENHANCED APYRASES - The present invention provides for design and therapeutic use of ADPase enhanced polypeptides, pharmaceutical compositions, and methods useful for preventing and reversing platelet aggregation and recruitment for the treatment and prevention of vascular disorders in mammals. | 02-05-2009 |
20110053221 | RECOMBINANT PRODUCTION OF AUTHENTIC HUMAN PROTEINS USING HUMAN CELL EXPRESSION SYSTEMS - The present invention relates to novel expression cassettes and vectors for efficiently producing authentic recombinant human proteins from stable cultures of novel human cell lines, the authentic recombinant proteins produced therefrom, and antibodies raised against those authentic recombinant proteins. | 03-03-2011 |
20130028880 | APYRASE THERAPY FOR BLEEDING CONDITIONS - This invention provides new methods of treating subjects experiencing or at risk of bleeding due to vascular injury, especially to the microvasculature and/or platelet desensitization. Examples of injury usefully treated by apyrase agents are patho-physiological conditions, ischemia reperfusion injury, injury from pharmacologic agents such as anticoagulants, antiplatelet agents, antithrombotics, thrombolytics, and/or immunosuppressants, and injury resulting from transplantation. Apyrase agents are also useful to maintain organ function when said organs are transplanted into an allogeneic recipient. | 01-31-2013 |
20130095062 | RECOMBINANT PRODUCTION OF AUTHENTIC HUMAN PROTEINS USING HUMAN CELL EXPRESSION SYSTEMS - The present invention relates to novel expression cassettes and vectors for efficiently producing authentic recombinant human proteins from stable cultures of novel human cell lines, the authentic recombinant proteins produced therefrom, and antibodies raised against those authentic recombinant proteins. | 04-18-2013 |
20130142775 | THERAPEUTIC APYRASE CONSTRUCTS, APYRASE AGENTS, AND PRODUCTION METHODS - This invention provides a new class of enhanced apyrases (EN-apyrases) with superior pharmacokinetic, pharmacodynamic, and pharmacochemical properties and which can be purified using simplified procedures. The invention further provides constructs for transforming a cell to produce these EN-apyrases. The EN-apyrase construct comprises sequences encoding a signal sequence, a linker, and a soluble apyrase. Also provided are preparations of apyrases and methods for producing apyrase in culture cells and purification thereof. | 06-06-2013 |
Patent application number | Description | Published |
20110023618 | LOW PRESSURE SENSOR DEVICE WITH HIGH ACCURACY AND HIGH SENSITIVITY - Pressure non-linearity in a low pressure sensor device formed from a silicon diaphragm with an embedded piezoresistive transducer is reduced by using a shallow boss or thin stiffener on an ultra-thin diaphragm while the pressure sensitivity of the device is increased with corner trenches. | 02-03-2011 |
20110232389 | Grooved Structure For Die-Mount And Media Sealing - Dual piezoresistive transducers formed into a single silicon die, are anodically bonded to a pedestal. Two separate pressure ports extend through a plastic housing. The port openings inside the housing are surrounded by a groove having a shape and size that accepts the pedestal. A thin, liquid adhesive is deposited into the groove and allowed to level out. The pedestal is placed into the adhesive and embeds itself therein. Adhesive overflow into the ports is avoided by dimensioning the groove and depositing an amount of adhesive that will fill the groove but not overflow when the pedestal is placed therein. Once the adhesive cures, the adhesive bond strength is greater due to the adhesive being in shear relative to the groove side walls and pedestal sidewalls. The grooved structure provides an apparatus and methodology for precise die mounting and media sealing. | 09-29-2011 |
20120216622 | ROBUST DESIGN OF HIGH PRESSURE SENSOR DEVICE - In a pressure sensing element made of piezoresistors formed into a silicon substrate, thermally-induced stresses on the piezoresistors and thermally-induced voltage offsets can be reduced by thinning the substrate prior to forming the resistors and then forming the resistors into the thinned-out recess. Forming a circular or disk-shaped recess in the substrate and then forming the resistors therein is believed to cause thermally-induced stresses to be evenly distributed and/or cancelled out on all four piezoresistors of a Wheatstone bridge circuit. | 08-30-2012 |
20130192378 | SEMICONDUCTOR SENSING DEVICE TO MINIMIZE THERMAL NOISE - An MEMS pressure sensor is designed to reduce or eliminate thermal noise, such as temperature offset voltage output. The pressure sensor includes a pressure sensing element having a diaphragm, and a cavity formed as part of the pressure sensing element, where the cavity receives a fluid such that the diaphragm at least partially deflects. The pressure sensing element also includes a plurality of piezoresistors, which are operable to generate a signal based on the amount of deflection in the diaphragm. At least one trench is integrally formed as part of the pressure sensing element, and an adhesive connects the pressure sensing element to the at least one substrate such that at least a portion of the adhesive is attached to the trench and redistributes thermally induced stresses on the pressure sensing element such that the thermally induced noise is substantially eliminated. | 08-01-2013 |
20140137653 | PIEZORESISTIVE TRANSDUCER WITH LOW THERMAL NOISE - In a MEMS PRT having a diaphragm that is located offset from the center of the die, thermally-induced thermal noise in the output of a Wheatstone bridge circuit is reduced by locating the Wheatstone bridge circuit away from the largest area of the die and supporting pedestal. | 05-22-2014 |
Patent application number | Description | Published |
20090176784 | ANTI-INFECTIVE AGENTS AND USES THEREOF - This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. | 07-09-2009 |
20090186912 | ANTI-INFECTIVE AGENTS AND USES THEREOF - This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. | 07-23-2009 |
20110009325 | CRYSTALLINE FORMS OF RAPAMYCIN ANALOGS - Provided is a rapamycin analog composition including a crystalline form of a rapamycin analog. The crystal can be a hydrate. dehydrate, solvate, or desolvate. The rampamycin analog can have a structure of Formula 1, which is optionally a prodrug, salt, derivative, or combination thereof: | 01-13-2011 |
20110009618 | METHODS OF MANUFACTURING CRYSTALLING FORMS OF RAPAMYCIN ANALOGS - A process for preparing a crystalline rapamycin analog includes: combining the rapamycin analog with an organic medium to form a mixture; incubating the mixture until the rapamycin analog crystallizes; and recovering the crystalline rapamycin analog. The organic medium can be a solvent, and the process can include causing the rapamycin analog to dissolve into the solvent, and incubating the solvent until the rapamycin analog crystallizes. The following can also be performed: forming a slurry of crystalline rapamycin analog; stirring the rapamycin analog mixture until the rapamycin analog crystallizes; saturating the rapamycin analog solution; forming a supersaturated rapamycin analog solution; combining an antisolvent with the rapamycin analog and the solvent to form a biphasic mixture, and incubating the biphasic mixture to cause a liquid-liquid phase split. | 01-13-2011 |
20120028908 | Methods of Manufacturing Crystalline Forms of Rapamycin Analogs - A process for preparing a crystalline rapamycin analog includes: combining the rapamycin analog with an organic medium to form a mixture; incubating the mixture until the rapamycin analog crystallizes; and recovering the crystalline rapamycin analog. The organic medium can be a solvent, and the process can include causing the rapamycin analog to dissolve into the solvent, and incubating the solvent until the rapamycin analog crystallizes. The following can also be performed: forming a slurry of crystalline rapamycin analog; stirring the rapamycin analog mixture until the rapamycin analog crystallizes; saturating the rapamycin analog solution; forming a supersaturated rapamycin analog solution; combining an antisolvent with the rapamycin analog and the solvent to form a biphasic mixture, and incubating the biphasic mixture to cause a liquid-liquid phase split. | 02-02-2012 |
20120157470 | SALTS AND CRYSTALLINE FORMS OF AN APOPTOSIS-INDUCING AGENT - Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}-sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide are suitable active pharmaceutical ingredients for pharmaceutical compositions useful in treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer. | 06-21-2012 |
20120189580 | ANTI-INFECTIVE AGENTS AND USES THEREOF - This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. | 07-26-2012 |
20120244119 | ANTI-INFECTIVE AGENTS AND USES THEREOF - This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. | 09-27-2012 |
20120245195 | NOVEL MONOHYDRATE OF AZAADAMANTANE DERIVATIVES - The invention relates to a crystalline monohydrate of (4s)-4-(5-phenyl-1,3,4-thiadiazol-2-yloxy)-1-azatricyclo[3.3.1.1 | 09-27-2012 |
20130096132 | AZAADAMANTANE DERIVATIVES AND METHODS OF USE - The invention relates to compounds that are azaadamantane derivatives, particularly ether- or amine-substituted azaadamantane derivatives and salts and prodrugs thereof, compositions comprising such compounds, methods of using such compounds and compositions, processes for preparing such compounds, and intermediates obtained during such processes. | 04-18-2013 |
20140213596 | SALTS AND CRYSTALLINE FORMS OF AN APOPTOSIS-INDUCING AGENT - Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}-sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide are suitable active pharmaceutical ingredients for pharmaceutical compositions useful in treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer. | 07-31-2014 |
20140275546 | AZAADAMANTANE FORMATE ESTER AND PROCESS FOR PREPARING AZAADAMANTANE DERIVATIVES - A compound, (4s)-1-azaadamantane-4yl formate ester, is described. In addition, a process is described for preparing (4s)-1-azaadamantane-4yl formate ester, aminothiadiazole-phenyl phosphate salt, bromothiadizole-phenyl or (4s)-4-(5-phenyl-1,3,4-thiadiazol-2-yloxy)-1-azatricyclo[3.3.1.1 | 09-18-2014 |
20140294766 | Anti-Infective Agents and Uses Thereof - This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. | 10-02-2014 |
Patent application number | Description | Published |
20090154884 | Multifiber MT-Type Connector and Ferrule Comprising V-Groove Lens Array and Method of Manufacture - A fiber optic ferrule, preferably an MT-type ferrule, and connector design is provided that includes a unitary v-groove lens array (v-lens). The v-lens comprises a plurality of lenses and corresponding plurality of open v-grooves to align optical fibers with the plurality of lenses. Because the v-groove lens array is a unitary structure, high precision manufacturing is required for only the v-groove lens array, and not for other components forming the ferrule. A housing holds the v-groove lens array and preferably comprises a cantilever configured to retain the optical fibers substantially within their corresponding v-grooves. An opening in the housing allows an adhesive to be placed in contact with the housing, optical fibers and v-groove lens array thereby retaining the various components in a fixed relationship. A fiber optic connector may include the fiber optic ferrule in accordance with the present invention disposed within a suitable connector housing. | 06-18-2009 |
20090175580 | Hybrid optical/electrical connector and adapter - A hybrid optical/electrical connector and mated adapter for terminating at least one hybrid optical/electrical cable containing an optical fiber and a conductor. The connector includes a crimp body having an elongated conductive insert with an interior passage for receiving the optical fiber and a non-conductive shell covering the insert. The insert has a contact portion exposed through the shell and an end extending beyond the shell for electrical engagement with the hybrid cable conductor. The adapter includes a non-conductive housing with a plug connector receiving channel. Within the plug receiving channel, a conductor extends longitudinally. The conductor has a contact point within the channel in alignment with the exposed contact portion of the insert so that when the connector is inserted within the receiving channel, the exposed contact portion of the insert and the conductor contact point of the adapter are in electrical engagement with one another. | 07-09-2009 |
20120213478 | OPTICAL FIBER CONNECTOR - An optical fiber connector includes a housing with at least one elongated cylindrical cavity, a fiber holder within the cavity including a ferrule which secures an optical fiber therein and a biasing member engaging the fiber holder to bias the ferrule towards an unmated position. A resilient metal latch is mounted on the housing for releasably securing the optical fiber connector to another component. A latch travel limiting structure prevents the latch from deflecting outside a desired predetermined path. Improved structures for mounting the latch on the housing and for creating a duplex connector assembly are also provided. | 08-23-2012 |
20140169743 | FERRULE ASSEMBLY WITH LATERAL FIBER INSERTION - An optical fiber ferrule assembly includes a ferrule body with an optical fiber receiving nest configured to receive a plurality of optical fibers. The nest opens laterally relative to the optical fiber axis to facilitate insertion of the optical fibers into the optical fiber receiving nest. The nest includes a plurality of arcuate surfaces configured to engage and align the optical fibers. A cover is secured to the ferrule body to secure the optical fibers within the optical fiber receiving nest. A ferrule and a method of assembly are also provided. | 06-19-2014 |
20140185990 | LENSED FERRULE ASSEMBLY WITH THERMAL EXPANSION COMPENSATION - An optical fiber assembly includes a ferrule body with a plurality of optical fibers. An end face of each optical fiber extends past the front face of the ferrule body. A beam expanding element is generally adjacent the front face of the ferrule body and has a lens array aligned with the optical fibers. An index matched resilient medium engages the rearwardly facing surface of the beam expanding element and the end faces of the optical fibers. | 07-03-2014 |
20140193120 | FERRULE ASSEMBLY WITH INTEGRAL LATCH - An optical fiber assembly includes a ferrule body with a plurality of optical fibers positioned therein. The assembly may include a beam expanding element adjacent the front face of the ferrule body with a lens array aligned with the optical fibers. A resilient latch is integrally formed with the beam expanding element or the ferrule body. | 07-10-2014 |
20140294395 | WIDE TEMPERATURE RANGE OPTICAL FIBER CONNECTOR WITH THERMAL EXPANSION COMPENSATION - An optical fiber assembly comprises an optical fiber having a forward end, a ferrule supporting the optical fiber, a beam expanding element aligned with the forward end of the optical fiber, and a thermal expansion compensation element adjacent the optical fiber to compensate for thermal expansion differences between the optical fiber and the ferrule. | 10-02-2014 |
20140321814 | MULTI-FIBER FERRULE WITH A LENS PLATE - An optical fiber assembly includes a ferrule body with a plurality of optical fibers and an end of each optical fiber positioned adjacent the front face of the ferrule body. A beam-expanding element is positioned adjacent the front face of the ferrule body including a lens array aligned with the optical fibers. The lens array is spaced from the optical fibers by a predetermined distance to form a gap with an index-matched medium within the gap. A method of manufacturing the optical fiber assembly is also provided. | 10-30-2014 |
Patent application number | Description | Published |
20080319981 | KNOWLEDGE PORTAL FOR ACCESSING, ANALYZING AND STANDARDIZING DATA - A method and system is provided to access one or more historical incident databases, for example, CDC, CPSC, DTI, AAPCC and the like, for standardizing the potentially differing categories and coding among the databases. The standardizing includes recoding of the categories by providing a unified set of categories reflective of similar categories found among the one or more databases, if any. Submission of search queries allows users to obtain unified data across the databases so that incident history statistics for one or more products tracked by commonly available databases may be easily acquired. The resulting reports and statistics may be used by various entities to understand historical incidents from multiple perspectives including, for example, injury and fatality statistics as a function of age group, type of injury, time periods, diagnosis, injury outcome, severity, and the like. Data may be presented in standardized formats or in any of the native database formats. | 12-25-2008 |
20110202536 | KNOWLEDGE PORTAL FOR ACCESSING, ANALYZING AND STANDARDIZING DATA - A method and system is provided to access one or more historical incident databases, for example, CDC, CPSC, DTI, AAPCC and the like, for standardizing the potentially differing categories and coding among the databases. The standardizing includes recoding of the categories by providing a unified set of categories reflective of similar categories found among the one or more databases, if any. Submission of search queries allows users to obtain unified data across the databases so that incident history statistics for one or more products tracked by commonly available databases may be easily acquired. The resulting reports and statistics may be used by various entities to understand historical incidents from multiple perspectives including, for example, injury and fatality statistics as a function of age group, type of injury, time periods, diagnosis, injury outcome, severity, and the like. Data may be presented in standardized formats or in any of the native database formats. | 08-18-2011 |
20120084220 | PRODUCT CERTIFICATION SYSTEM AND METHOD - Systems and methods are provided for generating a certificate of compliance for a product. A product control system (PCS) retrieves specification and/or regulatory data for a particular product and compares the retrieved data to test result data obtained for that particular product. The PCS generates a product certification if the test result data indicates that the product is in compliance with the specification data and/or the regulatory data. A product test plan generation system (PTPGS) enables a user to interact with a user interface to retrieve a test plan for a particular product. The test plan can be used to obtain test results for the particular product. | 04-05-2012 |
20120095930 | PRODUCT CERTIFICATION SYSTEM AND METHOD - Systems and methods are provided for generating a certificate of compliance for a product. A product control system (PCS) retrieves specification and/or regulatory data for a particular product and compares the retrieved data to test result data obtained for that particular product. The PCS generates a product certification if the test result data indicates that the product is in compliance with the specification data and/or the regulatory data. A product test plan generation system (PTPGS) enables a user to interact with a user interface to retrieve a test plan for a particular product. The test plan can be used to obtain test results for the particular product. | 04-19-2012 |
20120123954 | PRODUCT CERTIFICATION SYSTEM AND METHOD - Systems and methods are provided for generating a certificate of compliance for a product. A product control system (PCS) retrieves specification and/or regulatory data for a particular product and compares the retrieved data to test result data obtained for that particular product. The PCS generates a product certification if the test result data indicates that the product is in compliance with the specification data and/or the regulatory data. A product test plan generation system (PTPGS) enables a user to interact with a user interface to retrieve a test plan for a particular product. The test plan can be used to obtain test results for the particular product. | 05-17-2012 |
20120278711 | HAPTIC RESPONSE SYSTEM AND METHOD OF USE - An apparatus and method for assessing a hazard associated with an object are disclosed. The apparatus includes a haptic input/output device coupled to a computer with haptic modeling software and a display device. A virtual object and a virtual passageway are displayed on the display device. The virtual passageway includes a haptic layer along a surface thereof. Force applied by a user to the haptic input/output device causes a cursor on the display device to move the virtual object into the virtual passageway. An interaction of the virtual object with the haptic layer generates a virtual contact force which may be determined by the user sensing a corresponding tactile feedback force generated by the haptic input/output device and/or by the computer processor. The magnitude of the virtual contact force may be used to assess a hazard associated with the virtual object. | 11-01-2012 |
Patent application number | Description | Published |
20090179624 | RV CONVERTER WITH CURRENT MODE AND VOLTAGE MODE SWITCHING - A switched mode converter is disclosed that includes both voltage mode and current mode control. The switched mode converter also includes mode logic for switching between a voltage mode and a current mode. The converter includes current sensing circuitry for sensing the switcher current on the primary side of the transformer and the load current on the secondary side as well as voltage sensing circuitry for sensing the converter output voltage. When the load current is less than a predetermined value, the converter operates in a voltage mode. During the voltage mode, the output voltage of the voltage mode controller is used to control the duty cycle of a pulse width modulation (PWM) controller. When the load current is greater than a predetermined value, the converter operates in a current mode. In a current mode, the primary switcher current is used to control the PWM controller. As such, during a light load in which the converter is voltage controlled, there is no need for a minimum load to stabilize the control loop. In a current-mode, the control loop will have a relatively faster transient response and avoid flux imbalance in push-pull topology. As such, the converter provides the advantages of both known voltage controlled and current controlled switched mode converters. In addition, by the careful arrangement of the locations of a EMC filter, a primary heat sink, a secondary heat sink, a power transformer T1 and other power devices as well as a cooling fan, a smaller EMC filter can be used due to the primary heat sink performing a dual function of thermal management and additionally providing EMC shielding to prevent the noise, for example, the noise generated by the transformer, from reaching the filter. In addition, the primary heat sink is configured to face the air flow while the secondary heat sink is placed close to the fan with its fin direction the same as the direction of the air flow. As such, both the primary and the secondary heat sink get maximum air flow, allowing smaller heat sinks to be used in order to provide a reliable and cost-effective switched mode converter. | 07-16-2009 |
20100194353 | RV CONVERTER WITH CURRENT MODE AND VOLTAGE MODE SWITCHING - A switched mode converter is disclosed that includes both voltage mode and current mode control. The switched mode converter also includes mode logic for switching between a voltage mode and a current mode. The converter includes current sensing circuitry for sensing the switcher current on the primary side of the transformer and the load current on the secondary side as well as voltage sensing circuitry for sensing the converter output voltage. When the load current is less than a predetermined value, the converter operates in a voltage mode. During the voltage mode, the output voltage of the voltage mode controller is used to control the duty cycle of a pulse width modulation (PWM) controller. When the load current is greater than a predetermined value, the converter operates in a current mode. In a current mode, the primary switcher current is used to control the PWM controller. As such, during a light load in which the converter is voltage controlled, there is no need for a minimum load to stabilize the control loop. In a current-mode, the control loop will have a relatively faster transient response and avoid flux imbalance in push-pull topology. As such, the converter provides the advantages of both known voltage controlled and current controlled switched mode converters. In addition, by the careful arrangement of the locations of a EMC filter, a primary heat sink, a secondary heat sink, a power transformer T | 08-05-2010 |
Patent application number | Description | Published |
20090047323 | Medical Devices Containing Rapamycin Analogs - A medical device comprising a supporting structure capable of containing or supporting a pharmaceutically acceptable carrier or excipient, which carrier or excipient may contain one or more therapeutic agents or substances, with the carrier preferably including a coating on the surface thereof, and the coating containing the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. Drugs that are suitable for use in this invention include, but are not limited to Formula (I). This drug can be used in combination with another drug including those selected from anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these drugs. | 02-19-2009 |
20090047324 | Medical Devices Containing Rapamycin Analogs - A medical device comprising a supporting structure capable of containing or supporting a pharmaceutically acceptable carrier or excipient, which carrier or excipient may contain one or more therapeutic agents or substances, with the carrier preferably including a coating on the surface thereof, and the coating containing the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. Drugs that are suitable for use in this invention include, but are not limited to Formula (I). This drug can be used in combination with another drug including those selected from anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these drugs. | 02-19-2009 |
Patent application number | Description | Published |
20090054426 | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS - A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-β-hydroxysteroid dehydrogenase Type 1 enzyme activity. | 02-26-2009 |
20090192141 | METHODS OF USE OF INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME - The present invention relates to inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids. | 07-30-2009 |
20100152179 | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS - A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-β-hydroxysteroid dehydrogenase Type 1 enzyme activity. | 06-17-2010 |
20130059829 | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS - A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-β-hydroxysteroid dehydrogenase Type 1 enzyme activity. | 03-07-2013 |
20130338169 | METHODS OF USE OF INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME - The present invention relates to inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids. | 12-19-2013 |
Patent application number | Description | Published |
20080237899 | Break resistant joint - There is disclosed a portable misting fan formed by upper and lower body portions which are joined together along a joint. The joint is improved by providing the lower body portion with a non-circular neck portion along its top end, and wherein the upper body portion includes two halves which terminate in lower body collar sections, intended to be joined together in overlying relationship relative to the neck portion. A rail and groove system is employed as between the upper first and second body portions, and the neck portion, so that the rails will slidingly engage the grooves in the neck portion rendering the joint resistant to rotation. The neck portion includes an aperture into which a sleeve is press fitted, the sleeve includes upper and lower lips, and the lower body collar sections include inwardly extending flanges which overlie and engage the upper and lower lips formed in the sleeve, thereby brace and secure the pump assembly within the device. | 10-02-2008 |
20080237900 | Handheld water misting fan with improved air flow - The present invention is directed to an improved handheld water misting fan device wherein the power source compartment is positioned within the device at a location remote from the fan motor thereby to remove any structure from the area bounded by the fan shroud. The relocation of the power source compartment leaves the area bounded by the shroud substantially unobstructed thereby to improve air flow. The device is formed in a dog bone shaped configuration to provide a narrow handle section for improved grippability, and an enlarged fluid reservoir at the lower end thereof for greater reservoir capacity. | 10-02-2008 |
20090096399 | INTELLIGENT MOTORIZED APPLIANCES WITH MULTIPLE POWER SOURCES - A motorized portable appliance which monitors, and automatically selects, one of multiple power sources. The motorized portable appliance includes an electric motor, a secondary battery and at least one other source of electrical power, and an automatic control to switch between the secondary battery and the other source of electrical power, which may be mains electrical power, an external secondary battery, an on-board secondary battery, an automotive battery, a solar photovoltaic array, or a primary battery. Power conditioning circuitry converts power from the various power sources to a form compatible with the electric motor and recovers remaining power from depleted primary batteries. | 04-16-2009 |
20120319308 | Portable misting device - An improved portable misting fan device of the type formed by a body carrying fan means for creating and moving a stream of air, the body further provided with a reservoir and having a power source for driving the fan means and electrical means for driving the power source which further includes a powered mist generator having driving means and an actuator for actuating the mist generator, the mist generator being in fluid communication with the reservoir and a mist nozzle adapted to receive a fluid mist from the mist generator and deliver the same into the air stream created by the fan means. | 12-20-2012 |
Patent application number | Description | Published |
20080220610 | Silicon oxide polishing method utilizing colloidal silica - The inventive method comprises chemically-mechanically polishing a substrate with a polishing composition comprising a liquid carrier and sol-gel colloidal silica abrasive particles. | 09-11-2008 |
20090093131 | Low-temperature catalyzed formation of segmented nanowire of dielectric material - The present invention discloses a method of forming a segmented nanowire including: providing a substrate; pre-cleaning the substrate; pre-treating the substrate; forming and placing a catalyst over the substrate; and forming the segmented nanowire over the catalyst with recurring pulses of plasma-enhanced chemical vapor deposition (PECVD) of a dielectric material. | 04-09-2009 |
20100029181 | Methods and compositions for polishing silicon-containing substrates - The invention provides chemical-mechanical polishing (CMP) compositions and methods for polishing a silicon-containing substrate. A method of the invention comprises the steps of contacting a silicon-containing substrate with a polishing pad and an aqueous CMP composition, and causing relative motion between the polishing pad and the substrate while maintaining a portion of the CMP composition in contact with the surface of the substrate to abrade at least a portion of the substrate. The CMP composition comprises a ceria abrasive, a polishing additive bearing a functional group with a pK | 02-04-2010 |
20100190339 | COMPOSITIONS AND METHODS FOR CHEMICAL-MECHANICAL POLISHING OF PHASE CHANGE MATERIALS - The present invention provides a chemical-mechanical polishing (CMP) composition suitable for polishing a substrate comprising a phase change material (PCM), such as a germanium-antimony-tellurium (GST) alloy. The composition comprises a particulate abrasive material in combination with lysine, an optional oxidizing agent, and an aqueous carrier therefor. CMP methods for polishing a phase change material-containing substrate utilizing the composition are also disclosed. | 07-29-2010 |
20100200802 | OXIDATION-STABILIZED CMP COMPOSITIONS AND METHODS - The present invention provides a chemical-mechanical polishing (CMP) composition comprising an amino compound, a radical-forming oxidizing agent, a radical trapping agent capable of inhibiting radical-induced oxidation of the amino compound, and an aqueous carrier therefore. The radical trapping agent is a hydroxyl-substituted polyunsaturated cyclic compound, a nitrogenous compound, or a combination thereof. Optionally, the composition comprises a metal oxide abrasive (e.g., silica, alumina, titania, ceria, zirconia, or a combination of two or more of the foregoing abrasives). | 08-12-2010 |
20120280170 | COMPOSITIONS FOR POLISHING SILICON-CONTAINING SUBSTRATES - The invention provides chemical-mechanical polishing (CMP) compositions and methods for polishing a silicon-containing substrate. A method of the invention comprises the steps of contacting a silicon-containing substrate with a polishing pad and an aqueous CMP composition, and causing relative motion between the polishing pad and the substrate while maintaining a portion of the CMP composition in contact with the surface of the substrate to abrade at least a portion of the substrate. The CMP composition comprises a ceria abrasive, a polishing additive bearing a functional group with a pK | 11-08-2012 |
Patent application number | Description | Published |
20100283047 | PERYLENE-IMIDE SEMICONDUCTOR POLYMERS - Disclosed are new semiconductor materials prepared from perylene-imide copolymers. Such polymers can exhibit high n-type carrier mobility and/or good current modulation characteristics. In addition, the compounds of the present teachings can possess certain processing advantages such as solution-processability and/or good stability at ambient conditions. | 11-11-2010 |
20100326527 | NAPHTALENE-IMIDE SEMICONDUCTOR POLYMERS - Disclosed are new semiconductor materials prepared from naphthalene-imide copolymers. Such polymers can exhibit desirable electronic properties and can possess processing advantages including solution-processability and/or good stability at ambient conditions. | 12-30-2010 |
20110120558 | SEMICONDUCTOR MATERIALS PREPARED FROM RYLENE-(PI-ACCEPTOR)COPOLYMERS - Disclosed are new semiconductor materials prepared from rylene-(π-acceptor) copolymers. Such copolymers can exhibit high n-type carrier mobility and/or good current modulation characteristics. In addition, the polymers of the present teachings can possess certain processing advantages such as solution-processability and/or good stability at ambient conditions. | 05-26-2011 |
20110136333 | SEMICONDUCTOR MATERIALS AND METHODS OF PREPARATION AND USE THEREOF - Disclosed are new semiconductor materials prepared from dimeric perylene compounds. Such compounds can exhibit high n-type carrier mobility and/or good current modulation characteristics. In addition, the compounds of the present teachings can possess certain processing advantages such as solution-processability and/or good stability at ambient conditions. | 06-09-2011 |
20110155247 | Organic Semiconductors and Devices Incorporating Same - Disclosed are thionated fused-ring (aromatic) imides and diimides that can exhibit desirable electronic properties and can possess processing advantages including solution-processability and/or good stability at ambient conditions. | 06-30-2011 |
20110232764 | Conjugated Polymers and Devices Incorporating Same - Disclosed are conjugated polymers having desirable properties as semiconducting materials. Such polymers can exhibit desirable electronic properties and possess processing advantages including solution-processability and/or good stability. | 09-29-2011 |
20120264900 | THIENOCORONENE-IMIDE SEMICONDUCTING COMPOUNDS AND POLYMERS - Disclosed are new semiconductor materials prepared from thienocoronene-imide-based small molecule and/or polymeric compounds. Such compounds can exhibit high carrier mobility and/or good current modulation characteristics. In addition, the compounds of the present teachings can possess certain processing advantages such as solution-processability and/or good stability at ambient conditions. | 10-18-2012 |
20130168659 | Semiconducting Compounds and Related Compositions and Devices - Disclosed are new semiconductor materials prepared from thienocoronene-based compounds and related heteroaromatic analogs. Such compounds can exhibit high carrier mobility and/or good current modulation characteristics. In addition, the compounds of the present teachings can possess certain processing advantages such as solution-processability and/or good stability at ambient conditions. | 07-04-2013 |
20130200345 | Photocurable Polymeric Materials and Related Electronic Devices - Disclosed are photocurable polymers that can be used as active and/or passive organic materials in various electronic, optical, and optoelectronic devices. In some embodiments, the device can include a dielectric layer prepared from such photocurable polymers. In some embodiments, the device can include a passivation layer prepared from the polymers described herein. | 08-08-2013 |
20130247992 | Polymeric Blends and Related Optoelectronic Devices - Disclosed are all-polymer blends including an electron-acceptor polymer and an electron-donor polymer, capable of providing improved device performance, for example, as measured by power conversion efficiency, when used in photovoltaic cells. | 09-26-2013 |
20130270543 | PERYLENE-BASED SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF - Provided are semiconductors prepared from an enantiomerically enriched mixture of a nitrogen-functionalized rylene bis(dicarboximide) compound. Specifically, the enantiomerically enriched mixture has unexpected electron-transport efficiency compared to the racemate or either of the enantiomers in optically pure form. | 10-17-2013 |
Patent application number | Description | Published |
20080318136 | NON-AQUEOUS ELECTROLYTES - Non-aqueous electrolytes have poly(ethyleneoxide) siloxane or poly(ethyleneoxide) phosphate, a salt, and an electrode stabilizing additive. Electrochemical cells using such electrolytes may be prepared and exhibit improved charge carrying capacity. | 12-25-2008 |
20090081557 | LITHIUM BATTERIES USING POLY(ETHYLENE OXIDE)-BASED NON-AQUEOUS ELECTROLYTES - Lithium-air cells using poly(ethyleneoxide) (PEO) siloxane-based or poly(ethyleneoxide) phosphate-based electrolytes may be prepared and exhibit improved charge carrying capacity. Such PEO silioxanes and phosphates generally have the formulas Ia, Ib, Ic, Id, IIa, IIb, IIc, where: | 03-26-2009 |
20090286157 | Surface modification agents for lithium batteries - An active material for an electrochemical device may have a surface modification agent that is a silane, organometallic compound, or a mixture of two or more of such compounds. Both negative and positive electrodes may be prepared from the surface modified active materials. The surface of an electrode may be modified by adding the surface modification agent to a non-aqueous electrolyte used in constructing a battery. An electrode or active material may be modified with a surface modification agent in either the gas phase or in solution. Slurries of the active agent may be prepared and the surface modification agent added, the slurry then be used to cast an electrode that is then dried. | 11-19-2009 |
20100040954 | ELECTROLYTE SALTS FOR NONAQUEOUS ELECTROLYTES - Metal complex salts may be used in lithium ion batteries. Such metal complex salts not only perform as an electrolyte salt in a lithium ion batteries with high solubility and conductivity, but also can act as redox shuttles that provide overcharge protection of individual cells in a battery pack and/or as electrolyte additives to provide other mechanisms to provide overcharge protection to lithium ion batteries. The metal complex salts have at least one aromatic ring. The aromatic moiety may be reversibly oxidized/reduced at a potential slightly higher than the working potential of the positive electrode in the lithium ion battery. The metal complex salts may also be known as overcharge protection salts. | 02-18-2010 |
20110076572 | NON-AQUEOUS ELECTROLYTES FOR ELECTROCHEMICAL CELLS - A non-aqueous electrolyte includes an ionic electrolyte salt, and a non-aqueous electrolyte solvent that includes a mixture of siloxane or a silane or a mixture thereof, a sulfone, and a fluorinated ether or fluorinated ester or a mixture thereof, an ionic liquid, or a carbonate. | 03-31-2011 |
20110294018 | REDOX SHUTTLES FOR HIGH VOLTAGE CATHODES - A compound has general Formula I, II, III, or IV: | 12-01-2011 |
20120148731 | SURFACE MODIFICATION AGENTS FOR LITHIUM BATTERIES - A method includes modifying a surface of an electrode active material including providing a solution or a suspension of a surface modification agent; providing the electrode active material; preparing a slurry of the solution or suspension of the surface modification agent, the electrode active material, a polymeric binder, and a conductive filler; casting the slurry in a metallic current collector; and drying the cast slurry. | 06-14-2012 |
20120276450 | SURFACE MODIFICATION AGENTS FOR LITHIUM BATTERIES - A method includes modifying a surface of an electrode active material including providing a solution or a suspension of a surface modification agent; providing the electrode active material; preparing a slurry of the solution or suspension of the surface modification agent, the electrode active material, a polymeric binder, and a conductive filler; casting the slurry in a metallic current collector; and drying the cast slurry. | 11-01-2012 |
20130078532 | NON-AQUEOUS ELECTROLYTES FOR LITHIUM ION BATTERIES - An electrolyte includes a lithium salt; a polar aprotic solvent; a primary redox shuttle; and a lithium borate cluster salt. The lithium borate cluster salt may be compound of formula Li | 03-28-2013 |
20130224538 | ORGANIC NON-AQUEOUS CATION-BASED REDOX FLOW BATTERIES - The present invention provides a non-aqueous redox flow battery comprising a negative electrode immersed in a non-aqueous liquid negative electrolyte, a positive electrode immersed in a non-aqueous liquid positive electrolyte, and a cation-permeable separator (e.g., a porous membrane, film, sheet, or panel) between the negative electrolyte from the positive electrolyte. During charging and discharging, the electrolytes are circulated over their respective electrodes. The electrolytes each comprise an electrolyte salt (e.g., a lithium or sodium salt), a transition-metal free redox reactant, and optionally an electrochemically stable organic solvent. Each redox reactant is selected from an organic compound comprising a conjugated unsaturated moiety, a boron cluster compound, and a combination thereof. The organic redox reactant of the positive electrolyte is selected to have a higher redox potential than the redox reactant of the negative electrolyte. | 08-29-2013 |
20130273441 | LITHIUM BATTERIES USING POLY(ETHYLENE OXIDXE)-BASED NON-AQUEOUS ELECTROLYTES - Lithium-air cells employing poly(ethyleneoxide) phosphate-based electrolytes may be prepared and exhibit improved charge carrying capacity. Such PEO phosphates generally have the formulas IIa, IIb, IIc, where: | 10-17-2013 |
20140023941 | NON-AQUEOUS ELECTROLYTES FOR LITHIUM-AIR BATTERIES - A lithium-air cell includes a negative electrode; an air positive electrode; and a non-aqueous electrolyte which includes an anion receptor that may be represented by one or more of the formulas. | 01-23-2014 |